Although NK cells can recognise the tumour cells by loss of MHC-I, in situations of hypoxia, MHC-I can shed from the surface of cancer cells resulting in a downregulated expression of NKG2D and CXCR, serving as a mechanism of resistance to NK-mediated killing [91]. This evidence concerns the gene KLRK1 and cancer.